Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Repos Pharma

2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Operator of a drug research and development company designed to provide treatment for cancer. The company's drug research is focused on re-profiling known drugs for their efficiency in treating additional forms of cancer, enabling cancer patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Dag Hammarskjölds Väg 40 C
  • 752 37 Uppsala
  • Sweden
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Repos Pharma’s full profile, request a free trial.

Repos Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Repos Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Nxt2b Venture Capital Minority 000 0000 000000 0

Repos Pharma Board Members (1)

Name Representing Role Since Contact
Info
Angelica Loskog Nxt2b Chairman 000 0000